
Jean Sévigny
Chercheur universitaire
Axe Maladies infectieuses et immunitaires
Dernières nouvelles
Voir toutPublications
Voir tout-
article da Silva ÁC, Scholl JN, de Fraga Dias A, Weber AF, Morrone FB, Cruz-López O, Conejo-García A, Campos JM, Sévigny J, Figueiró F, Battastini AMO
Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme
Purinergic Signal 21 (1), 2025.
-
article Rodríguez-Martínez A, Torrejón-Escribano B, Eritja N, Dorca-Arévalo J, Gabaldón C, Sévigny J, Matias-Guiu X, Martín-Satué M
Endometrial epithelial cell organoids as tools for studying the CD39 family of enzymes and for validating enzyme inhibitors
Histol Histopathol 40 (2), 2025.
-
article Babou Kammoe RB, Sévigny J
Extracellular nucleotides in smooth muscle contraction
Biochem Pharmacol 220 2024.
Projets
- A recombinant soluble NTPDase8 as a novel biological treatment for inflammatory bowel disease, du 2021-10-01 au 2026-09-30
- Novel P2Y6 antagonists as a potential therapy for inflammatory bowel disease, du 2021-07-01 au 2025-06-30
- Ectonucleotidases and Extracellular Nucleotides in Smooth Muscle Cell Contraction, du 2023-04-01 au 2028-03-31
- Regroupement Québécois de Recherche sur la Fonction, l’Ingénierie et les Applications des Protéines, du 2024-04-01 au 2030-03-31
- Scaling up the production of recombinant human NTPDase8 in CHO expression system for in vivo testing, du 2023-09-01 au 2024-03-31